Thank Ketamine for the Telehealth Extension
The telemedicine extension is not just for psychedelics; easing these restrictions means relaxing them for other controlled substances as well.
Pharmaceuticals
-
Read more: Thank Ketamine for the Telehealth Extension -
Read more: Psychedelic Lobbying and Regulatory Capture Psychedelic Lobbying and Regulatory Capture
Not all lobbying campaigns are problematic — the goal should be for regulators to leverage industry insights while maintaining independence in decision-making.
-
Read more: Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing
What challenges arise for bioethicists when taking on commissions to work for organizations that are emerging out of the psychedelic underground?
-
Read more: Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation Psychedelic Inequities and Unexplored Risk: Colonization, Commercialization, and Regulation
This piece identifies three interrelated topics that warrant scrutiny as drivers of psychedelic racial health inequities.
-
Read more: Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control
Historic and contemporary discussions on psychedelic and MDMA research largely ignore theories on power, control, and abusive interpersonal relationships.
-
Read more: Should a Psychedelic Therapist Be Able to Continue Therapy for Their Patients Beyond Formal Integration Sessions? Should a Psychedelic Therapist Be Able to Continue Therapy for Their Patients Beyond Formal Integration Sessions?
Following psychedelic integration therapy, should the same lead therapist continue psychotherapy with their patients?
-
Read more: A Brief Political Economy of Hype A Brief Political Economy of Hype
It is only through public funding, regulation, and democratic community efforts that opportunities will expand, inequality diminish, and health care improve.
-
Read more: Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon
Here, we examine hype in the context of a perennial tension at the heart of patenting communication: between advertising innovation and keeping it secret.
-
Read more: When the Promises of a Policy Do Not Meet the Reality of Its Practice: Ethical Issues Within Oregon’s Measure 109 When the Promises of a Policy Do Not Meet the Reality of Its Practice: Ethical Issues Within Oregon’s Measure 109
In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.
-
Read more: Common Problems in Psychedelic Science, and How to Fix Them Common Problems in Psychedelic Science, and How to Fix Them
Psychedelic science appears to ignore many of the lessons learned from decades of research in other fields.
